Cancer researchers examining the use of artificial intelligence to detect early signs of breast cancer. Pediatricians tracking the long-term health of children born to mothers infected with the coronavirus during pregnancy. Scientists searching for links between diabetes and dementia.
All these projects at Columbia University were paid for with federal research grants that were abruptly terminated following the Trump administration’s decision to cut $400 million in funding to Columbia over concerns regarding the treatment of Jewish students.
Dozens of medical and scientific studies are ending, or at risk of ending, leaving researchers scrambling to find alternative funding. In some cases, researchers have already started informing study subjects that research is suspended.
“Honestly, I wanted to cry,” said Kathleen Graham, a 56-year-old nurse in the Bronx, upon learning that the diabetes study she had participated in for a quarter of a century was ending.
‘Colossally Wasteful’: Trump’s Cuts Imperil Medical Research at Columbia
